Foy, Victoria <br/><br/>
Targeting DNA damage in SCLC.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  12 2017 
 - 12-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2017.10.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aurora Kinases--therapeutic use<br/>Azepines--therapeutic use<br/>Benzimidazoles--therapeutic use<br/>Carbolines--therapeutic use<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Proliferation--drug effects<br/>Cytotoxins--therapeutic use<br/>DNA Damage--drug effects<br/>DNA Repair<br/>Etoposide--therapeutic use<br/>Genomic Instability--drug effects<br/>Heterocyclic Compounds, 4 or More Rings--therapeutic use<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Molecular Targeted Therapy--methods<br/>Phthalazines--therapeutic use<br/>Piperazines--therapeutic use<br/>Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Rad51 Recombinase--antagonists & inhibitors<br/>Small Cell Lung Carcinoma--drug therapy